• Exenatide OK'd for Type 2 Diabetes in Adolescents

    1 month ago - By MedPageToday

    Once-weekly exenatide extended-release is now FDA approved for children with type 2 diabetes ages 10 and up, AstraZeneca announced.
    Already approved in adults, the expanded label now holds an indication for...
    Read more ...

     

  • FDA OKs Extended-Release Exenatide for Children With T2D

    FDA OKs Extended-Release Exenatide for Children With T2D

    1 month ago - By Medscape

    This injectable medication is the second GLP-1 receptor agonist approved for pediatric type 2 diabetes, and the first with once-weekly administration.
    FDA Approvals
    Read more ...